BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15820959)

  • 1. An improved method for lupus anticoagulant detection.
    Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
    Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To mix or not to mix in lupus anticoagulant testing? That is the question.
    Tripodi A
    Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
    Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus anticoagulant (LA)].
    Gohchi K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():694-6. PubMed ID: 15658426
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI).
    Tripodi A; Chantarangkul V; Pengo V
    Lupus; 2012 Jun; 21(7):715-7. PubMed ID: 22635210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW; Smith MP; Savidge GF
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Working Group on Hemostasis of the Société Française de Biologie Clinique.
    Thromb Haemost; 1993 Nov; 70(5):781-6. PubMed ID: 8128435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays.
    Liestøl S; Wisløff F
    Thromb Res; 2005; 115(6):509-17. PubMed ID: 15792683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.